Login / Signup

Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma.

Yu-Yan HwangPek-Lan KhongYok Lam Kwong
Published in: Annals of hematology (2017)
Keyphrases
  • hodgkin lymphoma
  • low dose
  • high glucose
  • diabetic rats
  • high dose
  • disease activity
  • endothelial cells
  • rheumatoid arthritis
  • systemic lupus erythematosus